Doctor profile · Federal record
Dr. SHAHRYAR MAFI, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · MANASSAS, VA
- NPI 1750338505
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8100 ASHTON AVE, SUITE 200
MANASSAS, VA 201095622
(703) 331-0300
fax (703) 331-0254
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- May 22, 2013
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Virginia #0101055791
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750338505. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,594
Distinct HCPCS
10
Medicare allowed
$1,321,562
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,604 | 898 | $126 | |
J2785 |
Injection, regadenoson, 0.1 mg | 1,112 | 276 | $51 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 669 | 637 | $197 | |
A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 502 | 265 | $316 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 438 | 402 | $14 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 281 | 278 | $71 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 195 | 195 | $167 | |
78431 |
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 192 | 192 | $2,427 | |
93228 |
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 131 | 128 | $25 | |
93229 |
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 131 | 128 | $855 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 169. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$2,985
Transactions
94
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $551.55 | |
| Abbott Laboratories | 6 | $470.93 | |
| Merck Sharp & Dohme LLC | 11 | $292.75 | |
| HEARTFLOW, INC. | 4 | $247.79 | |
| Novo Nordisk Inc | 6 | $228.87 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $223.84 | |
| CVRx, Inc. | 2 | $222.14 | |
| PFIZER INC. | 6 | $175.09 | |
| SCPHARMACEUTICALS INC. | 3 | $159.46 | |
| Esperion Therapeutics, Inc. | 4 | $79.21 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $75.70 | |
| Amgen Inc. | 3 | $61.37 | |
| Janssen Pharmaceuticals, Inc | 3 | $51.88 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.16 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $36.92 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,445
Patients
1,259
Total drug cost
$865,027
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 544 | 191 | $10,127 |
| Rosuvastatin Calcium | Generic | 445 | 173 | $8,960 |
| Atorvastatin Calcium | Generic | 430 | 153 | $7,357 |
| Eliquis (Apixaban) | Brand | 341 | 93 | $419,631 |
| Amlodipine Besylate | Generic | 269 | 102 | $2,167 |
| Furosemide | Generic | 199 | 93 | $1,237 |
| Valsartan | Generic | 195 | 71 | $10,078 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 163 | 62 | $2,786 |
| Carvedilol | Generic | 160 | 55 | $2,032 |
| Entresto (Sacubitril/Valsartan) | Brand | 159 | 55 | $273,137 |